References
- Perez-Simón JA, Tabera S, Sarasquete ME, Díez-Campelo M, Canchado J, Sánchez-Abarca LI, . Mesencymal Stem Cells are functionally abnormal in patients with immune thrombocytopenic purpura. Cytotherapy 2009; in press: DOI: 10.1080/14653240903051558.
- Lopez-Villar O, Garcia JL, Sanchez-Guijo FM, Robledo C, Villaron EM, Hernandez-Campo P, . Both expanded and uncultured mesenchymal stem cells from MDS patients are genomically abnormal, showing a specific genetic profile for the 5q- syndrome. Leukemia 2009;234:664–72.
- Mercier F, Monczak Y, Francois M, Prchal J, Galipeau J. Bone marrow mesenchymal stromal cells of patients with myeloproliferative disorders do not carry the JAK2-V617F mutation. Exp Hematol 2009;373:416–20.
- Bacigalupo A, Valle M, Podesta M, Pitto A, Zocchi E, De Flora A, . T-cell suppression mediated by mesenchymal stem cells is deficient in patients with severe aplastic anemia. Exp Hematol 2005;337:819–27.